Antunes de Melo Oliveira, A. M., Trudeau, M. E., Moy, B., Saura Manich, C., Delaloge, S., & Hurvitz, S. (2021). Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial.
Citación estilo ChicagoAntunes de Melo Oliveira, Ana Mafalda, Maureen E. Trudeau, Beverly Moy, Cristina Saura Manich, Suzette Delaloge, y Sara Hurvitz. Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients With Central Nervous System Involvement From the NALA Trial. 2021.
Cita MLAAntunes de Melo Oliveira, Ana Mafalda, et al. Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients With Central Nervous System Involvement From the NALA Trial. 2021.
Precaución: Estas citas no son 100% exactas.